Placental Assessment in Diabetic Mothers

Placental Assessment in Early and Late Pregnancy in Diabetic Women

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04149548

Enrollment

100

Registered

2019-11-04

Start date

2019-11-05

Completion date

2020-12-01

Last updated

2020-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

Diabetes mellitus is one of the major heath problems

Detailed description

Maternal and fetal effects are edpected to be more than in diabetic mothers

Interventions

DIAGNOSTIC_TESTultrasound

Obstetric ultrasound to pregnant women

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 42 Years

Healthy volunteers

Inclusion criteria

* in control group A non diabetic pregnant women

Exclusion criteria

* Diabetic pregnant women And the reverse in group B

Design outcomes

Primary

Measure	Time frame	Description
The number of diabetic fetuses who will have undesirable effects	within 6 months	Number of fetuses with macrosomia and other diabetes effects

Countries

Egypt

Contacts

Primary ContactMahmoud Alalfy, PhD

mahmoudalalfy@ymail.com01002611058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026